- Dienstmann, R. (2023). Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials. Annals of Oncology, 34(11), 962-963. https://doi.org/10.1016/j.annonc.2023.10.002
Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials
on 22 de gener de 2024
with No hi ha comentaris
Deixa un comentari